drugset / Trial / NCT05642325
Vamikibart in Participants With Uveitic Macular Edema
RandomizedParallel-groupDouble-blindTreatment
Summary
This study will assess the efficacy and safety of vamikibart in participants with uveitic macular edema.
Timeline
- Start
- 2023-03-23
- Primary completion
- 2025-05-07
- Completion
- 2025-12-24
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Vamikibart | Monoclonal antibody | — | Intravitreal |